Heart Failure/Transplantation
Review | Takotsubo syndrome: more frequent in women, more dangerous in men
12 May, 2023 | 13:21h | UTCSee all articles in the series here
Management of patients with heart failure and preserved ejection fraction
10 May, 2023 | 15:49h | UTCManagement of patients with heart failure and preserved ejection fraction – Heart
Related: 2023 ACC expert consensus on management of heart failure with preserved ejection fraction
Commentary on Twitter
Education in Heart: Management of patients with HFpEF https://t.co/SA7d0WH891 pic.twitter.com/59BK9OgYNe
— Heart_BMJ (@Heart_BMJ) April 29, 2023
Cohort Study | Long-term beta-blocker use in MI patients without heart failure or LVSD not linked to better cardiovascular outcomes
5 May, 2023 | 15:29h | UTCEditorial: Should beta-blockers be recommended after myocardial infarction when left ventricular ejection fraction is normal? – Heart (free for a limited period)
News Release: Study questions long term beta blocker use for heart attack patients – BMJ Newsroom
Related Systematic Review: Beta‐blockers in patients without heart failure after myocardial infarction – Cochrane Library.
Scientific Statement | Iron deficiency in heart failure
3 May, 2023 | 15:25h | UTC
ISHLT Guidelines for the care of heart transplant recipients
3 May, 2023 | 15:09h | UTC
Scientific Statement | Role of natriuretic peptides in the diagnosis and management of heart failure
2 May, 2023 | 14:05h | UTC
A systematic review on clinical guidelines of home health care in heart failure patients
28 Apr, 2023 | 12:41h | UTC
2023 ACC expert consensus on management of heart failure with preserved ejection fraction
21 Apr, 2023 | 13:10h | UTCCommentaries:
New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF – TCTMD
Review | Management of cardiogenic shock after acute coronary syndromes
18 Apr, 2023 | 13:27h | UTCManagement of cardiogenic shock after acute coronary syndromes – BJA Education
Assessing heart failure risk: waist-to-height ratio outperforms BMI in HFrEF patients
31 Mar, 2023 | 13:49h | UTCCommentary: Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives – TCTMD
Acute heart failure: diagnostic–therapeutic pathways and preventive strategies — a real-world clinician’s guide
28 Mar, 2023 | 14:45h | UTC
AHA Scientific Statement | Supervised exercise training for chronic heart failure with preserved ejection fraction
22 Mar, 2023 | 13:46h | UTCNews Release: Exercise therapy is safe, may improve quality of life for many people with heart failure – American Heart Association
Key Points: Supervised Exercise Training for Chronic HFpEF – American College of Cardiology
Review | Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis
20 Mar, 2023 | 13:21h | UTCCardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis – European Heart Journal
Review | Cardiac rehabilitation for heart failure: ‘Cinderella’ or evidence-based pillar of care?
17 Mar, 2023 | 13:00h | UTC
Review | Pathophysiological gaps, diagnostic challenges, and uncertainties in cardiac sarcoidosis
17 Mar, 2023 | 12:47h | UTC
Review | Transcatheter interventions for heart failure
17 Mar, 2023 | 12:44h | UTCTranscatheter interventions for heart failure – EuroIntervention
Review | Heart failure with preserved ejection fraction
15 Mar, 2023 | 15:18h | UTCHeart Failure With Preserved Ejection Fraction: A Review – JAMA (free for a limited period)
Author Interview: Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction – JAMA
ESC Consensus Statement | Inotropic therapy in patients with advanced heart failure
15 Mar, 2023 | 15:14h | UTC
SR | Myocardial revascularization in patients with ischemic cardiomyopathy: for whom and how
14 Mar, 2023 | 13:46h | UTC
Burden, trends, and inequalities of heart failure globally, 1990 to 2019
14 Mar, 2023 | 13:35h | UTC
M-A | Opioids for breathlessness in heart failure have no significant benefits and increase adverse effects
9 Mar, 2023 | 14:11h | UTCSummary: The study aimed to assess the effectiveness of opioids in treating breathlessness in patients with heart failure and to evaluate their adverse effects. The authors conducted a systematic review of randomized controlled trials (RCTs) and included eight studies with 271 patients.
The results showed that opioids did not provide significant benefits in managing breathlessness in advanced HF and significantly increased the risk of adverse events such as nausea, vomiting, and constipation.
The authors suggest that opioids should be considered only as a last resort when other interventions have failed or in emergency situations.
Article: Effect of opioids for breathlessness in heart failure: a systematic review and meta-analysis – Heart
#ACC23 – RCT | Five-year follow-up after transcatheter repair of secondary mitral regurgitation
6 Mar, 2023 | 14:28h | UTCFive-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
COAPT at 5 Years: MitraClip Still Ahead, but Deaths and Crossovers Cast Shadows – TCTMD
Commentary on Twitter
Transcatheter repair of secondary mitral regurgitation for heart failure was associated with a lower rate of hospitalization for heart failure and lower all-cause mortality than medical therapy at 5 years of follow-up.
Full COAPT trial: https://t.co/rcJ6RQEMAX #ACC23/#WCCardio pic.twitter.com/sM8R50oaBq
— NEJM (@NEJM) March 5, 2023
Guideline | Acute mechanical circulatory support
27 Feb, 2023 | 13:04h | UTC
[Not published yet] M-A | Too little sodium can be harmful to heart failure patients
24 Feb, 2023 | 13:59h | UTCSummary: New research presented at the American College of Cardiology’s annual scientific session suggests that heart failure patients restricting their dietary sodium intake to levels below the standard recommended maximum of 2.3 grams per day do not have additional benefits and may be at increased risk of death. The study analyzed nine randomized controlled trials that assessed different levels of sodium restriction and found that patients following a diet with a sodium intake target below 2.5 grams per day were 80% more likely to die than those following a diet with a target of 2.5 grams per day or more. The researchers recommend establishing a safe level of sodium consumption instead of overly restricting sodium.
News release: Too Little Sodium Can be Harmful to Heart Failure Patients – American College of Cardiology
Worsening heart failure: nomenclature, epidemiology, and future directions
15 Feb, 2023 | 16:06h | UTC


